Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco M Muggia

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Anti-Cancer Drugs|April 20, 2004
Re: 'Radiation recall dermatitis induced by pegylated liposomal doxorubicin'Franco M Muggia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Intraperitoneal Therapy for Ovarian CancerFranco M Muggia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Boosting bioavailability to topotecan: what do we gain?Franco M Muggia
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
The Benefits of Reducing My Hours to Half-Time (That Is, Three-Quarter Time)Franco M Muggia
The New England Journal of Medicine|June 11, 2005
Phase 1 clinical trials in oncologyFranco M Muggia
Seminars in Oncology|February 24, 2005
Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancersFranco M Muggia
The Oncologist|February 21, 2002
Thoughts about September 11, 2001: civilization's resilience and tenacityFranco M Muggia
Seminars in Oncology|February 24, 2005
Relevance of chemotherapy dose and schedule to outcomes in ovarian cancerFranco M Muggia
Molecular Cancer Therapeutics|April 23, 2009
Heidelberger symposium on the 50th anniversary of fluoropyrimidinesFranco M Muggia
Anti-Cancer Drugs|April 8, 2014
Introduction: why a supplement on taxanes?Franco M Muggia
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Anti-Cancer Drugs|April 20, 2004
Re: 'Radiation recall dermatitis induced by pegylated liposomal doxorubicin'Franco M Muggia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Intraperitoneal Therapy for Ovarian CancerFranco M Muggia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Boosting bioavailability to topotecan: what do we gain?Franco M Muggia
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
The Benefits of Reducing My Hours to Half-Time (That Is, Three-Quarter Time)Franco M Muggia
The New England Journal of Medicine|June 11, 2005
Phase 1 clinical trials in oncologyFranco M Muggia
Seminars in Oncology|February 24, 2005
Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancersFranco M Muggia
The Oncologist|February 21, 2002
Thoughts about September 11, 2001: civilization's resilience and tenacityFranco M Muggia
Seminars in Oncology|February 24, 2005
Relevance of chemotherapy dose and schedule to outcomes in ovarian cancerFranco M Muggia
Molecular Cancer Therapeutics|April 23, 2009
Heidelberger symposium on the 50th anniversary of fluoropyrimidinesFranco M Muggia
Anti-Cancer Drugs|April 8, 2014
Introduction: why a supplement on taxanes?Franco M Muggia
Pageof 6